Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Effects of Club Cell Secretory Protein in Chronic Lung Transplant Rejection
EF 2024-25
Résumé
Lung transplants can help save the lives of people with fatal lung diseases. However, after transplantation, the patient immune system recognizes the transplanted lung as foreign and attacks it: this is called rejection. Over time, this rejection and other injuries lead to scarring of the lung called chronic lung allograft dysfunction (CLAD). As a result, most lung transplants only last an average of 6 years, the lowest of all organ transplants. CLAD is thought to start with injury to the breathing passages (airways), making it harder for them to heal, leading to increased inflammation and scarring. Epithelial club cells are one of the many cells that line airways. Club cells assist in healing and renewal of other cells by producing club cell secretory protein (CCSP) which can decrease inflammation and scarring. CLAD is associated with both a decrease in CCSP and club cells.Lung CCSP supplementation, in animals, has been shown to reduce scarring and increase cell proliferation. However, the effects of CCSP have not been studied in humans with lung transplants. We hypothesize that CCSP supplementation into the airways of lung transplant patients will improve airway cell response to injury by increasing cell proliferation and decreasing inflammation and scarring. We aim to investigate this by adding CCSP to injured and uninjured human airway cells, measuring markers of proliferation, inflammation, and scarring, and then comparing these levels to those of un-supplemented cells. This research will help determine whether inhaled CCSP supplementation is a possible therapy to help slow down or reduce CLAD, thereby helping lung transplant patients live longer, healthier lives.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530317
Name
Carter Zoeen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effects of Club Cell Secretory Protein in Chronic Lung Transplant Rejection
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Airway Epithelial Cells; Airway Epithelial Regeneration; Chronic Lung Allograft Dysfunction (Clad); Club Cell Secretory Protein (Ccsp); Fibrosis; Lung Allograft Rejection; Lung Transplant; Obliterative Bronchiolitis
Abstract
Lung transplants can help save the lives of people with fatal lung diseases. However, after transplantation, the patient immune system recognizes the transplanted lung as foreign and attacks it: this is called rejection. Over time, this rejection and other injuries lead to scarring of the lung called chronic lung allograft dysfunction (CLAD). As a result, most lung transplants only last an average of 6 years, the lowest of all organ transplants. CLAD is thought to start with injury to the breathing passages (airways), making it harder for them to heal, leading to increased inflammation and scarring. Epithelial club cells are one of the many cells that line airways. Club cells assist in healing and renewal of other cells by producing club cell secretory protein (CCSP) which can decrease inflammation and scarring. CLAD is associated with both a decrease in CCSP and club cells.Lung CCSP supplementation, in animals, has been shown to reduce scarring and increase cell proliferation. However, the effects of CCSP have not been studied in humans with lung transplants. We hypothesize that CCSP supplementation into the airways of lung transplant patients will improve airway cell response to injury by increasing cell proliferation and decreasing inflammation and scarring. We aim to investigate this by adding CCSP to injured and uninjured human airway cells, measuring markers of proliferation, inflammation, and scarring, and then comparing these levels to those of un-supplemented cells. This research will help determine whether inhaled CCSP supplementation is a possible therapy to help slow down or reduce CLAD, thereby helping lung transplant patients live longer, healthier lives.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Carter, Zoeen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~